Elicio Therapeutics (NASDAQ:ELTX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Elicio Therapeutics (ELTX) operate in?

Elicio Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Elicio Therapeutics Stock (NASDAQ: ELTX) stock price, news, charts, stock research, profile.

Open	$4.90
Close	$4.60
Volume / Avg.	13.58K / 22.73K
Day Range	$4.60 - $4.90
52 Wk Range	2.96 - 11.45
Market Cap	$55.92M
P/E Ratio	5.30
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	0.34%
Days to Cover	2.58

Recent News

Why Is Cancer Vaccine Developer Elicio Therapeutics Stock Trading Lower On Friday?

Elicio Therapeutics announced promising preliminary data from the AMPLIFY-7P Phase 1a study of ELI-002 7P, showing extended median disease-free survival in patients with mKRAS-driven solid tumors.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Jun

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$4.90
Close	$4.60
Volume / Avg.	13.58K / 22.73K
Day Range	$4.60 - $4.90
52 Wk Range	2.96 - 11.45
Market Cap	$55.92M
P/E Ratio	5.30
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	0.34%
Days to Cover	2.58

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Elicio Therapeutics (ELTX) stock?

You can purchase shares of Elicio Therapeutics (NASDAQ:ELTX) through any online brokerage.

View our list of the best stock brokerages

Who are Elicio Therapeutics (ELTX) competitors?

Other companies in Elicio Therapeutics’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Serina Therapeutics (AMEX:SER), Kezar Life Sciences (NASDAQ:KZR), Fortress Biotech (NASDAQ:FBIO) and Gain Therapeutics (NASDAQ:GANX).

What is the forecast, or price target, for Elicio Therapeutics (ELTX) stock?

Elicio Therapeutics has a consensus price target of $10.00.

What is the current price for Elicio Therapeutics (ELTX)?

The stock price for Elicio Therapeutics (NASDAQ: ELTX) is $5.19 last updated October 1, 2024 at 7:55 AM EDT.

Does Elicio Therapeutics (ELTX) pay a dividend?

There are no upcoming dividends for Elicio Therapeutics.

When is Elicio Therapeutics (NASDAQ:ELTX) reporting earnings?

Elicio Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.

Is Elicio Therapeutics (ELTX) going to split?

There is no upcoming split for Elicio Therapeutics.

What sector and industry does Elicio Therapeutics (ELTX) operate in?

Elicio Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Top Stock Ideas Sent Daily — Join and Gain Your Edge